Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China · Delayed Price · Currency is CNY
11.33
+0.07 (0.62%)
Feb 4, 2026, 3:04 PM CST

SHE:301060 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
744.95828.95861.2665.81351.96412.08
Trading Asset Securities
----420.93120.63
Cash & Short-Term Investments
744.95828.95861.2665.81772.89532.71
Cash Growth
8.78%-3.74%29.35%-13.85%45.09%9.77%
Accounts Receivable
730.16808.631,0332,249819.61540.05
Other Receivables
8.0414.546.0811.837.898.18
Receivables
738.2823.171,0402,261827.5548.23
Inventory
319.96306.09367.71401.52139.44147.13
Prepaid Expenses
--0.118.45--
Other Current Assets
40.5840.4357.9751.5627.2324.84
Total Current Assets
1,8441,9992,3273,3891,7671,253
Property, Plant & Equipment
460.03482.58509.74220.96241.11117.37
Long-Term Investments
1.471.7614.0616.74--
Goodwill
7.667.6615.2417.6430.0930.09
Other Intangible Assets
21.1724.4526.513.0614.8112.89
Long-Term Accounts Receivable
-0.25----
Long-Term Deferred Tax Assets
73.2373.8248.9530.1313.3914.07
Long-Term Deferred Charges
21.1730.0437.1749.632.0539.56
Other Long-Term Assets
2.334.128.6710.166.974.63
Total Assets
2,4312,6232,9873,7472,1051,472
Accounts Payable
446.97388.99502.36858.69253.03125.34
Accrued Expenses
24.0461.9850.07253.6490.2451.97
Short-Term Debt
50.0395.11214.59182.162-
Current Portion of Long-Term Debt
27.2115.1415.15---
Current Portion of Leases
-12.0810.7716.8113.67-
Current Income Taxes Payable
11.5212.549.7351.7628.9110.74
Current Unearned Revenue
10.9115.126.628.739.2818.46
Other Current Liabilities
28.1914.6413.5522.0315.8511.49
Total Current Liabilities
598.87615.59822.831,414412.98218.01
Long-Term Debt
117.5133.7145.77---
Long-Term Leases
10.1118.2721.0745.6250.03-
Long-Term Unearned Revenue
7.610.4211.9414.682.666.12
Other Long-Term Liabilities
26.3425.025.09---
Total Liabilities
760.438031,0071,474465.67224.13
Common Stock
400.52400.52400.52400.52400.52352.46
Additional Paid-In Capital
553.96553.96553.96553.96552.8461.84
Retained Earnings
646.94727.31836.751,109611.62407.97
Treasury Stock
-23.01-23.01-10.26---
Comprehensive Income & Other
-0.65-0.65-0.65---
Total Common Equity
1,5781,6581,7802,0631,5651,222
Minority Interest
92.57162.21199.85209.4974.8825.12
Shareholders' Equity
1,6701,8201,9802,2731,6401,247
Total Liabilities & Equity
2,4312,6232,9873,7472,1051,472
Total Debt
204.85274.29407.35244.5965.7-
Net Cash (Debt)
540.11554.66453.85421.22707.19532.71
Net Cash Growth
46.01%22.21%7.75%-40.44%32.75%9.77%
Net Cash Per Share
1.341.371.121.052.011.51
Filing Date Shares Outstanding
398.52398.52399.77400.52400.52352.46
Total Common Shares Outstanding
398.52398.52399.77400.52400.52352.46
Working Capital
1,2451,3831,5041,9751,3541,035
Book Value Per Share
3.964.164.455.153.913.47
Tangible Book Value
1,5491,6261,7392,0331,5201,179
Tangible Book Value Per Share
3.894.084.355.073.803.35
Buildings
-337.04333.0258.7728.9428.94
Machinery
-332.87342296.39290.65232.89
Construction In Progress
-0.999.52-16.98-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.